Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report)’s stock price traded down 7.5% during trading on Tuesday . The stock traded as low as C$2.12 and last traded at C$2.12. 140 shares traded hands during trading, a decline of 96% from the average session volume of 3,192 shares. The stock had previously closed at C$2.29.
Genscript Biotech Stock Performance
The firm’s 50 day moving average price is C$2.19 and its 200 day moving average price is C$2.09.
Genscript Biotech Company Profile
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.
Featured Articles
- Five stocks we like better than Genscript Biotech
- Comparing and Trading High PE Ratio Stocks
- Wall Street’s Sleeping Giant: Is Amazon About to Wake Up?
- CD Calculator: Certificate of Deposit Calculator
- Checkmate in the Cloud: ServiceNow’s Shopping Spree
- Business Services Stocks Investing
- The Contrarian Case for MSTR Amid MSCI Delisting Debacle
Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
